r5/resource_types/specialized/medication_definition/medication_definition library
Classes
- AdministrableProductDefinition
- AdministrableProductDefinition A medicinal product in the final form which is suitable for administering to a patient (after any mixing of multiple components, dissolution etc. has been performed).
- AdministrableProductDefinitionProperty
- AdministrableProductDefinitionProperty A medicinal product in the final form which is suitable for administering to a patient (after any mixing of multiple components, dissolution etc. has been performed).
- AdministrableProductDefinitionRouteOfAdministration
- AdministrableProductDefinitionRouteOfAdministration A medicinal product in the final form which is suitable for administering to a patient (after any mixing of multiple components, dissolution etc. has been performed).
- AdministrableProductDefinitionTargetSpecies
- AdministrableProductDefinitionTargetSpecies A medicinal product in the final form which is suitable for administering to a patient (after any mixing of multiple components, dissolution etc. has been performed).
- AdministrableProductDefinitionWithdrawalPeriod
- AdministrableProductDefinitionWithdrawalPeriod A medicinal product in the final form which is suitable for administering to a patient (after any mixing of multiple components, dissolution etc. has been performed).
- ClinicalUseDefinition
- ClinicalUseDefinition A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionContraindication
- ClinicalUseDefinitionContraindication A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionIndication
- ClinicalUseDefinitionIndication A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionInteractant
- ClinicalUseDefinitionInteractant A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionInteraction
- ClinicalUseDefinitionInteraction A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionOtherTherapy
- ClinicalUseDefinitionOtherTherapy A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionUndesirableEffect
- ClinicalUseDefinitionUndesirableEffect A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- ClinicalUseDefinitionWarning
- ClinicalUseDefinitionWarning A single issue - either an indication, contraindication, interaction or an undesirable effect for a medicinal product, medication, device or procedure.
- Ingredient
- Ingredient An ingredient of a manufactured item or pharmaceutical product.
- IngredientManufacturer
- IngredientManufacturer An ingredient of a manufactured item or pharmaceutical product.
- IngredientReferenceStrength
- IngredientReferenceStrength An ingredient of a manufactured item or pharmaceutical product.
- IngredientStrength
- IngredientStrength An ingredient of a manufactured item or pharmaceutical product.
- IngredientSubstance
- IngredientSubstance An ingredient of a manufactured item or pharmaceutical product.
- ManufacturedItemDefinition
- ManufacturedItemDefinition The definition and characteristics of a medicinal manufactured item, such as a tablet or capsule, as contained in a packaged medicinal product.
- ManufacturedItemDefinitionComponent
- ManufacturedItemDefinitionComponent The definition and characteristics of a medicinal manufactured item, such as a tablet or capsule, as contained in a packaged medicinal product.
- ManufacturedItemDefinitionConstituent
- ManufacturedItemDefinitionConstituent The definition and characteristics of a medicinal manufactured item, such as a tablet or capsule, as contained in a packaged medicinal product.
- ManufacturedItemDefinitionProperty
- ManufacturedItemDefinitionProperty The definition and characteristics of a medicinal manufactured item, such as a tablet or capsule, as contained in a packaged medicinal product.
- MedicinalProductDefinition
- MedicinalProductDefinition A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionCharacteristic
- MedicinalProductDefinitionCharacteristic A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionContact
- MedicinalProductDefinitionContact A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionCrossReference
- MedicinalProductDefinitionCrossReference A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionName
- MedicinalProductDefinitionName A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionOperation
- MedicinalProductDefinitionOperation A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionPart
- MedicinalProductDefinitionPart A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- MedicinalProductDefinitionUsage
- MedicinalProductDefinitionUsage A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs).
- PackagedProductDefinition
- PackagedProductDefinition A medically related item or items, in a container or package.
- PackagedProductDefinitionContainedItem
- PackagedProductDefinitionContainedItem A medically related item or items, in a container or package.
- PackagedProductDefinitionLegalStatusOfSupply
- PackagedProductDefinitionLegalStatusOfSupply A medically related item or items, in a container or package.
- PackagedProductDefinitionPackaging
- PackagedProductDefinitionPackaging A medically related item or items, in a container or package.
- PackagedProductDefinitionProperty
- PackagedProductDefinitionProperty A medically related item or items, in a container or package.
- RegulatedAuthorization
- RegulatedAuthorization Regulatory approval, clearance or licencing related to a regulated product, treatment, facility or activity that is cited in a guidance, regulation, rule or legislative act. An example is Market Authorization relating to a Medicinal Product.
- RegulatedAuthorizationCase
- RegulatedAuthorizationCase Regulatory approval, clearance or licencing related to a regulated product, treatment, facility or activity that is cited in a guidance, regulation, rule or legislative act. An example is Market Authorization relating to a Medicinal Product.
- SubstanceDefinition
- SubstanceDefinition The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionCharacterization
- SubstanceDefinitionCharacterization The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionCode
- SubstanceDefinitionCode The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionMoiety
- SubstanceDefinitionMoiety The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionMolecularWeight
- SubstanceDefinitionMolecularWeight The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionName
- SubstanceDefinitionName The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionOfficial
- SubstanceDefinitionOfficial The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionProperty
- SubstanceDefinitionProperty The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionRelationship
- SubstanceDefinitionRelationship The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionRepresentation
- SubstanceDefinitionRepresentation The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionSourceMaterial
- SubstanceDefinitionSourceMaterial The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceDefinitionStructure
- SubstanceDefinitionStructure The detailed description of a substance, typically at a level beyond what is used for prescribing.
- SubstanceNucleicAcid
- SubstanceNucleicAcid Nucleic acids are defined by three distinct elements: the base, sugar and linkage. Individual substance/moiety IDs will be created for each of these elements. The nucleotide sequence will be always entered in the 5’-3’ direction.
- SubstanceNucleicAcidLinkage
- SubstanceNucleicAcidLinkage Nucleic acids are defined by three distinct elements: the base, sugar and linkage. Individual substance/moiety IDs will be created for each of these elements. The nucleotide sequence will be always entered in the 5’-3’ direction.
- SubstanceNucleicAcidSubunit
- SubstanceNucleicAcidSubunit Nucleic acids are defined by three distinct elements: the base, sugar and linkage. Individual substance/moiety IDs will be created for each of these elements. The nucleotide sequence will be always entered in the 5’-3’ direction.
- SubstanceNucleicAcidSugar
- SubstanceNucleicAcidSugar Nucleic acids are defined by three distinct elements: the base, sugar and linkage. Individual substance/moiety IDs will be created for each of these elements. The nucleotide sequence will be always entered in the 5’-3’ direction.
- SubstancePolymer
- SubstancePolymer Properties of a substance specific to it being a polymer.
- SubstancePolymerDegreeOfPolymerisation
- SubstancePolymerDegreeOfPolymerisation Properties of a substance specific to it being a polymer.
- SubstancePolymerMonomerSet
- SubstancePolymerMonomerSet Properties of a substance specific to it being a polymer.
- SubstancePolymerRepeat
- SubstancePolymerRepeat Properties of a substance specific to it being a polymer.
- SubstancePolymerRepeatUnit
- SubstancePolymerRepeatUnit Properties of a substance specific to it being a polymer.
- SubstancePolymerStartingMaterial
- SubstancePolymerStartingMaterial Properties of a substance specific to it being a polymer.
- SubstancePolymerStructuralRepresentation
- SubstancePolymerStructuralRepresentation Properties of a substance specific to it being a polymer.
- SubstanceProtein
- SubstanceProtein A SubstanceProtein is defined as a single unit of a linear amino acid sequence, or a combination of subunits that are either covalently linked or have a defined invariant stoichiometric relationship. This includes all synthetic, recombinant and purified SubstanceProteins of defined sequence, whether the use is therapeutic or prophylactic. This set of elements will be used to describe albumins, coagulation factors, cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes, toxins, toxoids, recombinant vaccines, and immunomodulators.
- SubstanceProteinSubunit
- SubstanceProteinSubunit A SubstanceProtein is defined as a single unit of a linear amino acid sequence, or a combination of subunits that are either covalently linked or have a defined invariant stoichiometric relationship. This includes all synthetic, recombinant and purified SubstanceProteins of defined sequence, whether the use is therapeutic or prophylactic. This set of elements will be used to describe albumins, coagulation factors, cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes, toxins, toxoids, recombinant vaccines, and immunomodulators.
- SubstanceReferenceInformation
- SubstanceReferenceInformation
- SubstanceReferenceInformationGene
- SubstanceReferenceInformationGene
- SubstanceReferenceInformationGeneElement
- SubstanceReferenceInformationGeneElement
- SubstanceReferenceInformationTarget
- SubstanceReferenceInformationTarget
- SubstanceSourceMaterial
- SubstanceSourceMaterial Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.
- SubstanceSourceMaterialAuthor
- SubstanceSourceMaterialAuthor Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.
- SubstanceSourceMaterialFractionDescription
- SubstanceSourceMaterialFractionDescription Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.
- SubstanceSourceMaterialHybrid
- SubstanceSourceMaterialHybrid Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.
- SubstanceSourceMaterialOrganism
- SubstanceSourceMaterialOrganism Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.
- SubstanceSourceMaterialOrganismGeneral
- SubstanceSourceMaterialOrganismGeneral Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.
- SubstanceSourceMaterialPartDescription
- SubstanceSourceMaterialPartDescription Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex.